Contact
searchSearch
HMP Global

Advertisement

ADVERTISEMENT

Commentary

Headshot of Mark Munger, PharmD, University of Utah
Commentary
A Polypill as Secondary Cardiovascular Prevention
09/01/2022
Mark Munger, PharmD, University of Utah, reviews data demonstrating the benefits of a polypill strategy to simplify treatment and improve adherence among adults at risk for cardiovascular disease.
Mark Munger, PharmD, University of Utah, reviews data demonstrating the benefits of a polypill strategy to simplify treatment and improve adherence among adults at risk for cardiovascular disease.
Mark Munger, PharmD, University...
09/01/2022
Pharmacy Learning Network
Headshot of Ann Latner, JD
Commentary
Jury Sides With Pharmacist Who Refused to Dispense Morning After Pill
08/29/2022
Ann W Latner, JD, details a lawsuit filed against a Minnesota pharmacist after he refused to fill a prescription for an emergency contraceptive pill due to his religious beliefs.
Ann W Latner, JD, details a lawsuit filed against a Minnesota pharmacist after he refused to fill a prescription for an emergency contraceptive pill due to his religious beliefs.
Ann W Latner, JD, details a...
08/29/2022
Pharmacy Learning Network
Prescription pad and pill bottles
Commentary
Pros and Cons of Mail-Order Pharmacy Services: Views From Clinicians, Patients
08/24/2022
In this commentary, Yvette C Terrie walks through the history of mail-order pharmacy services and asks health care practitioners and the patients they serve to share their opinions.
In this commentary, Yvette C Terrie walks through the history of mail-order pharmacy services and asks health care practitioners and the patients they serve to share their opinions.
In this commentary, Yvette C...
08/24/2022
Pharmacy Learning Network

Advertisement

Headshot of Ann Latner, JD
Commentary
North Carolina Pharmacy Ordered to Pay $300,000 for Unlawful Opioid Distribution
08/16/2022
In addition to civil penalties, the pharmacy will be prohibited from filling certain "red flag" prescriptions, the Department of Justice announced.
In addition to civil penalties, the pharmacy will be prohibited from filling certain "red flag" prescriptions, the Department of Justice announced.
In addition to civil penalties,...
08/16/2022
Pharmacy Learning Network
Headshot of Mark Munger, PharmD, University of Utah
Commentary
Suboptimal Heart Health in the United States: Concerns and Solutions
08/10/2022
Citing data on sleep disorders, weight gain, and more, Dr Munger calls for greater attention to improving the US population's cardiovascular health.
Citing data on sleep disorders, weight gain, and more, Dr Munger calls for greater attention to improving the US population's cardiovascular health.
Citing data on sleep disorders,...
08/10/2022
Pharmacy Learning Network
Bottle with pills pouring out
Commentary
Exploring the Potential Benefits of Metformin Beyond Diabetes
08/03/2022
Yvette C Terrie walks through research on metformin's impact on a variety of disease states other than diabetes, including colorectal cancer and age-related macular degeneration.
Yvette C Terrie walks through research on metformin's impact on a variety of disease states other than diabetes, including colorectal cancer and age-related macular degeneration.
Yvette C Terrie walks through...
08/03/2022
Pharmacy Learning Network

Advertisement

Headshot of Mark Munger, PharmD, University of Utah
Commentary
Addressing Shortcomings in Research: Walgreens Launches Clinical Trial Business
08/01/2022
Dr Munger discusses the lack of diverse representation in clinical trials and breaks down Walgreens's recent efforts to close these gaps.
Dr Munger discusses the lack of diverse representation in clinical trials and breaks down Walgreens's recent efforts to close these gaps.
Dr Munger discusses the lack of...
08/01/2022
Pharmacy Learning Network
Headshots of Pavel Lavitas, PharmD, BCPS, and Amanda O'Hora
Commentary
Navigating Reimbursement and Access Challenges for Novel Cell and Gene Therapies
07/26/2022
In this commentary, Pavel Lavitas, PharmD, BCPS, and Amanda O'Hora review reimbursement and patient access challenges related to approved cell and gene-based therapies.
In this commentary, Pavel Lavitas, PharmD, BCPS, and Amanda O'Hora review reimbursement and patient access challenges related to approved cell and gene-based therapies.
In this commentary, Pavel...
07/26/2022
Pharmacy Learning Network
Headshot of Ann Latner, JD
Commentary
Pharmacy Pays $1.5 Million to Resolve Controlled Substances Allegations
07/20/2022
Ann W Latner, JD, reviews a case wherein a Michigan pharmacy allegedly ignored red flags before filling prescriptions for opioids and other controlled substances.
Ann W Latner, JD, reviews a case wherein a Michigan pharmacy allegedly ignored red flags before filling prescriptions for opioids and other controlled substances.
Ann W Latner, JD, reviews a case...
07/20/2022
Pharmacy Learning Network

Advertisement

Stock photo of healthy food and a stethoscope
Commentary
Getting to the Heart of the Matter: Study Reveals Only 20% of Americans Have Optimal Heart Health
07/14/2022
Yvette C Terrie, BS Pharm, RPh, consultant pharmacist, reviews findings from a recent study that ranked the cardiovascular health of US adults and children using updated metrics from the American Heart Association.
Yvette C Terrie, BS Pharm, RPh, consultant pharmacist, reviews findings from a recent study that ranked the cardiovascular health of US adults and children using updated metrics from the American Heart Association.
Yvette C Terrie, BS Pharm, RPh,...
07/14/2022
Pharmacy Learning Network

Advertisement

Advertisement

Advertisement

Stay Informed & Sign Up Today

Pharmacy Learning Network Newsletter

Advertisement

Video Insights

Videos
David Rubin, MD, on JAK Inhibitors: Small But Mighty
11/22/2023
Dr Rubin reviews his presentation from the Advances in Inflammatory Bowel Disease regional meeting on the latest information on the safety and efficacy of Janus kinase inhibitors for the treatment of inflammatory bowel disease.
Dr Rubin reviews his presentation from the Advances in Inflammatory Bowel Disease regional meeting on the latest information on the safety and efficacy of Janus kinase inhibitors for the treatment of inflammatory bowel disease.
Dr Rubin reviews his...
11/22/2023
Pharmacy Learning Network
Videos
Advantages and Drawbacks of Lecanemab in Alzheimer Disease Treatment
11/10/2023
Dr Shulz discusses the FDA-approved lecanemab for the treatment of AD.
Dr Shulz discusses the FDA-approved lecanemab for the treatment of AD.
Dr Shulz discusses the...
11/10/2023
Pharmacy Learning Network
Videos
Immunosuppressants or Immunomodulators? Biologic Agents for Psoriasis
10/27/2023
In this exclusive interview, Dr Ronald Vender goes over the highly effective targeted biologic therapies used to treat psoriasis.
In this exclusive interview, Dr Ronald Vender goes over the highly effective targeted biologic therapies used to treat psoriasis.
In this exclusive interview, Dr...
10/27/2023
Pharmacy Learning Network
Videos
Application of Dupilumab to Pediatric Patients With Atopic Dermatitis
10/27/2023
In this feature video, Dr Abigail Cline discusses current literature to assess reported efficacies, side effects, and risks of using dupilumab to treat atopic dermatitis in pediatric patients.
In this feature video, Dr Abigail Cline discusses current literature to assess reported efficacies, side effects, and risks of using dupilumab to treat atopic dermatitis in pediatric patients.
In this feature video, Dr...
10/27/2023
Pharmacy Learning Network
Videos
Patient Considerations When Prescribing Lecanemab for Alzheimer Disease
10/06/2023
Dr Paul Schulz discusses the newly FDA-approved lecanemab for the treatment of AD.
Dr Paul Schulz discusses the newly FDA-approved lecanemab for the treatment of AD.
Dr Paul Schulz discusses the...
10/06/2023
Pharmacy Learning Network
Headshots of Chris Fausel, PharmD, MHA, BCOP; Erin Hamai Tom, PharmD, APh, MBA, BCACP; and Ryan Nix, PharmD, MMHC
Videos
Specialty Pharmacy Next: Focus on Distribution Processes, Data Utilization, New Drugs, and More
07/18/2023
In this roundtable, cochairs of Specialty Pharmacy Next gather to discuss pertinent topics on the agenda such as white and brown bagging practices and data usage for program growth, as well as who may benefit most from attending the meeting.
In this roundtable, cochairs of Specialty Pharmacy Next gather to discuss pertinent topics on the agenda such as white and brown bagging practices and data usage for program growth, as well as who may benefit most from attending the meeting.
In this roundtable, cochairs of...
07/18/2023
Pharmacy Learning Network
Videos
Leaders in Pharmacy Come Together to Discuss and Debate Oncology-Related Developments
06/28/2021
Chris Fausel, PharmD, Val Adams, PharmD, Kirollos Hanna, PharmD, and Lisa Holle, PharmD, cochairs of Great Debates and Updates Oncology Pharmacy, come together to discuss this new CPE event aimed at educating pharmacists interested in...
Chris Fausel, PharmD, Val Adams, PharmD, Kirollos Hanna, PharmD, and Lisa Holle, PharmD, cochairs of Great Debates and Updates Oncology Pharmacy, come together to discuss this new CPE event aimed at educating pharmacists interested in...
Chris Fausel, PharmD, Val Adams,...
06/28/2021
Pharmacy Learning Network
Expanded FDA Approval Improves Care Access, Rates of Flu Cases
Videos
Expanded FDA Approval Improves Care Access, Rates of Flu Cases
04/19/2021
Gregg Sylvester, MD, MPH, chief medical officer, and David Ross, vice president, commercial operations for North America, both at Seqirus, discuss the recent FDA approval for Flucelvax Quadrivalent, explain what the expanded indication means...
Gregg Sylvester, MD, MPH, chief medical officer, and David Ross, vice president, commercial operations for North America, both at Seqirus, discuss the recent FDA approval for Flucelvax Quadrivalent, explain what the expanded indication means...
Gregg Sylvester, MD, MPH, chief...
04/19/2021
Pharmacy Learning Network
Identifying Drug Diversion Differences in Retail Pharmacies Compared With Health Systems
Videos
Identifying Drug Diversion Differences in Retail Pharmacies Compared With Health Systems
12/28/2020
Tom Knight, founder and CEO, Invistics, identifies drug diversion differences in a hospital or health system versus a retail pharmacy, and explains what retail pharmacies can do to better detect and address drug diversion.
Tom Knight, founder and CEO, Invistics, identifies drug diversion differences in a hospital or health system versus a retail pharmacy, and explains what retail pharmacies can do to better detect and address drug diversion.
Tom Knight, founder and CEO,...
12/28/2020
Pharmacy Learning Network
Identifying Risks of Human Error, Workarounds in Pharmacy
Videos
Identifying Risks of Human Error, Workarounds in Pharmacy
12/22/2020
Matthew Grissinger, RPh, FISMP, FASCP, director of Error Reporting Programs, Institute for Safe Medication Practices, discusses how human error, various at-risk behaviors, as well as workarounds taken by staff members all impact outcomes and...
Matthew Grissinger, RPh, FISMP, FASCP, director of Error Reporting Programs, Institute for Safe Medication Practices, discusses how human error, various at-risk behaviors, as well as workarounds taken by staff members all impact outcomes and...
Matthew Grissinger, RPh, FISMP,...
12/22/2020
Pharmacy Learning Network

Advertisement

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2024 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use